
Proprio announced today the successful first-in-human use of its surgical technology platform, Paradigm. Paradigm fuses light field imaging technology with artificial intelligence (AI) to give surgical teams 3D visualization of both anatomical structures and the surgical environment.
Using an array of sensors and cameras, Paradigm captures high-definition multimodal images during surgery and integrates them with preoperative scans to provide surgeons with real-time mapping of the anatomy.
In addition to augmenting navigation capabilities during a procedure, Paradigm also collects large amounts of pre-op and intra-op data to inform future surgical decision-making and improve surgical efficiency and accuracy.
“The successful first-in-human use of Paradigm marks a pivotal milestone in our journey to enhance the future of surgery,” said Gabriel Jones, CEO and co-founder of Proprio. “We are honored by this validation of the potential of our platform to reshape surgical practices and drive meaningful reductions in costs, increasing access to essential healthcare.”
Proprio’s Paradigm secured FDA 510(k) clearance and significant additional funding earlier this year.
Source: Proprio
Proprio announced today the successful first-in-human use of its surgical technology platform, Paradigm. Paradigm fuses light field imaging technology with artificial intelligence (AI) to give surgical teams 3D visualization of both anatomical structures and the surgical environment.
Using an array of sensors and cameras, Paradigm captures...
Proprio announced today the successful first-in-human use of its surgical technology platform, Paradigm. Paradigm fuses light field imaging technology with artificial intelligence (AI) to give surgical teams 3D visualization of both anatomical structures and the surgical environment.
Using an array of sensors and cameras, Paradigm captures high-definition multimodal images during surgery and integrates them with preoperative scans to provide surgeons with real-time mapping of the anatomy.
In addition to augmenting navigation capabilities during a procedure, Paradigm also collects large amounts of pre-op and intra-op data to inform future surgical decision-making and improve surgical efficiency and accuracy.
“The successful first-in-human use of Paradigm marks a pivotal milestone in our journey to enhance the future of surgery,” said Gabriel Jones, CEO and co-founder of Proprio. “We are honored by this validation of the potential of our platform to reshape surgical practices and drive meaningful reductions in costs, increasing access to essential healthcare.”
Proprio’s Paradigm secured FDA 510(k) clearance and significant additional funding earlier this year.
Source: Proprio
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.





